非人灵长类动物CD4池的定量PET成像
本研究在18只外周血CD4+T细胞计数约20至2400/μl的恒河猴中,用[89Zr]Zr-CD4R1-F(ab΄)2和/或[89Zr]Zr-ibalizumab进行静态PET扫描至注射后144小时,并在3只免疫功能正常猴中行4小时动态扫描、动脉采血、代谢物评价与模型拟合以估算淋巴结、脾和肠道CD4受体结合潜能。结果显示CD4特异性结合主要位于淋巴结和脾,肠道摄取低,且肠道对全身CD4池的贡献低于脾。
要点
- CD4特异性结合主要定位于淋巴结和脾,肠道摄取低。
- 免疫功能正常与免疫缺陷猕猴的淋巴组织摄取存在显著差异。
- 肠道对全身CD4池的贡献低于脾的贡献。
核心结论
- 与CD4+组织特异性结合的大部分定位于淋巴结和脾,肠道摄取极少。
- 完全定量研究得出的结合潜能显示,肠道对全身CD4池的贡献低于脾的贡献。
研究设计与样本
- 在18只外周血CD4+T细胞计数约20至2400/μl的恒河猴中,于注射[89Zr]Zr-CD4R1-F(ab΄)2和/或[89Zr]Zr-ibalizumab后至144小时(6天)行静态PET扫描。
- 在3只免疫功能正常猴中行4小时动态扫描、动脉采血、代谢物评价与模型拟合,以估算淋巴结、脾和肠道的CD4受体结合潜能。
- 对大小肠行离体研究以验证在体图像。
主要发现
- [89Zr]Zr-CD4R1-F(ab΄)2与[89Zr]Zr-ibalizumab在淋巴组织中的生物分布相似,可清晰勾画淋巴结和脾的CD4池。
- 免疫功能正常与免疫缺陷猕猴之间的淋巴组织摄取存在显著差异。
- [89Zr]Zr-CD4R1-F(ab΄)2和[89Zr]Zr-ibalizumab在肠道的摄取低,且未感染与SIV感染CD4耗竭猴之间无差异。
- 大小肠离体研究证实了在体图像所见。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Previous SPECT and PET semi-quantitative in vivo imaging studies in monkeys have demonstrated specific uptake of radiolabeled rhesus recombinant anti-CD4 monoclonal antibody fragment CD4R1-F(ab΄)2 in the spleen and clusters of lymph nodes (LNs) but yielded conflicting results of imaging the gut CD4 + T-cell pool. Here, using PET dynamic imaging with kinetic analysis, we performed a fully quantitative CD4 imaging in rhesus macaques. METHODS: The biodistributions of [89Zr]Zr-CD4R1-F(ab΄)2 and/or of [89Zr]Zr-ibalizumab were performed with static PET scans up to 144 h (6 days) post-injection in 18 rhesus macaques with peripheral blood CD4 + T cells/μl ranging from ~ 20 to 2400. Fully quantitative analysis with a 4-h dynamic scan, arterial sampling, metabolite evaluation, and model fitting was performed in three immunocompetent monkeys to estimate the binding potential of CD4 receptors in the LNs, spleen, and gut. RESULTS: The biodistributions of [89Zr]Zr-CD4R1-F(ab΄)2 and [89Zr]Zr-ibalizumab were similar in lymphoid tissues with a clear delineation of the CD4 pool in the LNs and spleen and a significant difference in lymphoid tissue uptake between immunocompetent and immunocompromised macaques. Consistent with our previous SPECT imaging of [99mTc]Tc-CD4R1-F(ab΄)2, the [89Zr]Zr-CD4R1-F(ab΄)2 and [89Zr]Zr-Ibalizumab uptakes in the gut were low and not different between uninfected and SIV-infected CD4-depleted monkeys. Ex vivo studies of large and small intestines confirmed the in vivo images. CONCLUSION: The majority of specific binding to CD4 + tissue was localized to LNs and spleen with minimal uptake in the gut. Binding potential derived from fully quantitative studies revealed that the contribution of the gut is lower than the spleen's contribution to the total body CD4 pool.
引用
- Kim I, Srinivasula S, DeGrange P, et al. Quantitative PET imaging of the CD4 pool in nonhuman primates. Eur J Nucl Med Mol Imaging. 2022. PMID: 36028577. doi:10.1007/s00259-022-05940-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。